https://www.selleckchem.com/pr....oducts/GSK1059615.ht
SUMMARY The barriers to implementation in practice remain small study sizes, variations in supplement dosage and methodology, and differences in primary endpoints. Randomized, blinded trials with a justifiable sample size, adequate doses, monitored compliance and measures of clinically important endpoints are required to move these findings to a higher level of evidence for implementation into clinical practice.PURPOSE OF REVIEW Controversies about the adequate amount of energy to deliver to critically ill patients are still going on
إعجاب
علق
شارك
